Correlation Between Tempest Therapeutics and Pharvaris

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Pharvaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Pharvaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Pharvaris BV, you can compare the effects of market volatilities on Tempest Therapeutics and Pharvaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Pharvaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Pharvaris.

Diversification Opportunities for Tempest Therapeutics and Pharvaris

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tempest and Pharvaris is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Pharvaris BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharvaris BV and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Pharvaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharvaris BV has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Pharvaris go up and down completely randomly.

Pair Corralation between Tempest Therapeutics and Pharvaris

Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 8.67 times more return on investment than Pharvaris. However, Tempest Therapeutics is 8.67 times more volatile than Pharvaris BV. It trades about 0.03 of its potential returns per unit of risk. Pharvaris BV is currently generating about 0.06 per unit of risk. If you would invest  161.00  in Tempest Therapeutics on August 30, 2024 and sell it today you would lose (65.01) from holding Tempest Therapeutics or give up 40.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tempest Therapeutics  vs.  Pharvaris BV

 Performance 
       Timeline  
Tempest Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tempest Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Pharvaris BV 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tempest Therapeutics and Pharvaris Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tempest Therapeutics and Pharvaris

The main advantage of trading using opposite Tempest Therapeutics and Pharvaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Pharvaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharvaris will offset losses from the drop in Pharvaris' long position.
The idea behind Tempest Therapeutics and Pharvaris BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators